Lupin moves up on getting nod to enter into digital healthcare space
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
Lupin is currently trading at Rs. 1248.60, up by 1.70 points or 0.14% from its previous closing of Rs. 1246.90 on the BSE.
The scrip opened at Rs. 1256.90 and has touched a high and low of Rs. 1256.90 and Rs. 1234.55 respectively. So far 40367 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1267.50 on 02-Jun-2021 and a 52 week low of Rs. 828.65 on 27-Jul-2020.
Last one week high and low of the scrip stood at Rs. 1267.50 and Rs. 1190.55 respectively. The current market cap of the company is Rs. 56789.43 crore.
The promoters holding in the company stood at 46.86%, while Institutions and Non-Institutions held 40.46% and 12.69% respectively.
Lupin has received approval from board of directors to enter into the digital healthcare space with a focus to provide a digital therapeutics platform for doctors and patients in India. The Company recently incorporated a new entity in the name of Lupin Digital Health, as a wholly owned subsidiary, which will undertake this.
Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India.
